Owlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Owlet Monitor Duo that gets the snapshot of baby's wellbeing; Owlet Smart Sock that tracks baby's heart rate and oxygen while sleeping and get notifications if baby needs to be checked on; Owlet Cam, a smart HD video baby monitor; and Dream Lab, an online and personalized infant sleep solution. The company was founded in 2012 and is based in Lehi, Utah.
IPO Year: 2020
Exchange: NYSE
Website: owletcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/23/2025 | $7.00 | Outperform | Northland Capital |
| 10/6/2021 | $12.00 → $5.00 | Neutral | Citigroup |
| 10/5/2021 | $8.50 → $5.50 | Buy → Neutral | BofA Securities |
| 9/8/2021 | $8.50 | Buy | BofA Securities |
| 8/5/2021 | $11.00 | Neutral | Citigroup |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Northland Capital initiated coverage of Owlet with a rating of Outperform and set a new price target of $7.00
Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously
BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously
BofA Securities initiated coverage of Owlet with a rating of Buy and set a new price target of $8.50
Citigroup initiated coverage of Owlet with a rating of Neutral and set a new price target of $11.00
S-3 - Owlet, Inc. (0001816708) (Filer)
S-8 - Owlet, Inc. (0001816708) (Filer)
10-Q - Owlet, Inc. (0001816708) (Filer)
8-K - Owlet, Inc. (0001816708) (Filer)
8-K - Owlet, Inc. (0001816708) (Filer)
424B5 - Owlet, Inc. (0001816708) (Filer)
424B5 - Owlet, Inc. (0001816708) (Filer)
SCHEDULE 13D/A - Owlet, Inc. (0001816708) (Subject)
SCHEDULE 13D/A - Owlet, Inc. (0001816708) (Subject)
8-K - Owlet, Inc. (0001816708) (Filer)
Fastest customizable press release news feed in the world
This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet's data through Locus Health's platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in remote patient monitoring, for more integrated infant health management. The collaboration connects data from Owlet's FDA-cleared prescription device, BabySat®, directly into the Locus Health platform, giving healthcare providers ongoing and secure access to vital infant health information after hospital disch
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet's Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, November 13, 2025, at 4:30 p.m. ET. Q3 2025 Financial Highlights: Record Q3 Revenue of $32.0 million, up 44.6% from Q3 2024 Record Q3 Gross Profit of $16.2 million; Q3 Gross Margin of 50.6%, down 150 basis points from Q3 2024 driven primarily by tariff impact Record Q3 Operating Income of
Collaboration bridges home and hospital, creating a secure pathway for pediatric insights to be managed and shared. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces a partnership with Rhapsody, a global leader in digital health enablement and interoperability, to securely connect infant health insights from Owlet's FDA-cleared, prescription pulse oximeter, BabySat®, directly into their existing electronic health record (EHR) workflows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112744527/en/Owlet partners with Rhapsody to securely connect infant vital signs from
Earning the first-ever SGS Cybersecurity Mark in the baby monitor category, Owlet reinforces its leadership in safety, security, privacy, and innovation. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced that its newest video monitoring device, Dream Sight, is the first and only baby monitor to earn an SGS Cybersecurity Mark, a global certification that recognizes the highest standards in international cybersecurity and privacy. Dream Sight was tested by Brightsight, an SGS company and global leader in cybersecurity evaluations. For parents, this independent recognition provides extra reassurance that Owlet delivers trusted digital
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2025 financial results after market close on Thursday, November 13, 2025. Owlet's President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 646-844-6383 (international) and reference Access Code 428622. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay w
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced the pricing of an underwritten public offering of 4,196,000 shares of the Company's Class A common stock (the "Offering"). The shares of Class A common stock are being sold at a public offering price of $7.15 per share, before underwriting discounts and commissions. All of the shares in the Offering are to be sold by the Company. The gross proceeds to Owlet from the Offering are expected to be approximately $30.0 million, before deducting underwriting discounts and commissions and other offering expenses. The Company has granted the underwriters of the Offering a 30-day option to purc
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced a proposed underwritten public offering of its Class A common stock (the "Offering"). In addition, Owlet intends to grant the underwriters a 30-day option to purchase additional shares of its Class A common stock in an amount up to 15% of the shares offered in the Offering, at the public offering price per share less underwriting discounts and commissions. All of the shares in the Offering are being offered by Owlet. Owlet intends to use the net proceeds of the proposed Offering to support continued commercialization and research and development, and for general corporate purposes.
Owlet expands its global footprint, entering one of the world's most promising digital health markets, with CDSCO-approved technology. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces that the Central Drugs Standard Control Organization (CDSCO) approved Dream Sock® for distribution. This marks a significant milestone for the Company as it now prepares to launch its integrated monitoring devices, including Dream Sock®, Dream Sight™, and Dream Duo™, across India in early 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015040875/en/Owlet Dream Duo, including Dream
Owlet, Inc. (NYSE:OWLT) (the "Company" or "Owlet"), the pioneer of smart infant monitoring, today announced that on September 30, 2025, the Compensation Committee of its Board of Directors approved an equity inducement award to Jordan Thompson, the Company's Vice President and Corporate Controller. The award was made in connection with Mr. Thompson joining the Company as a material inducement to employment. The equity inducement award consists of 129,863 restricted stock units ("Inducement RSUs"), which will vest as to 33.33% of the underlying shares on May 15, 2026, and as to the remainder in equal installments on a quarterly basis through May 15, 2028, subject to Mr. Thompson's continue
LEHI, Utah, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Owlet, Inc. (NYSE:OWLT) has released the following notice: IN THE UNITED STATES DISTRICT COURTFOR THE CENTRAL DISTRICT OF CALIFORNIA IN RE OWLET, INC. SHAREHOLDER DERIVATIVE LITIGATIONLead Case No. 2:24-cv-07258-FLA-PVC This Document Relates to:NOTICE OF PROPOSED DERIVATIVE SETTLEMENT ALL ACTIONS. NOTICE OF PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE MATTERS, HEARING THEREON, AND RIGHT TO APPEAR TO:ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON STOCK OF OWLET, INC. ("OWLET" OR "THE COM
Live finance-specific insights
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet's Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, November 13, 2025, at 4:30 p.m. ET. Q3 2025 Financial Highlights: Record Q3 Revenue of $32.0 million, up 44.6% from Q3 2024 Record Q3 Gross Profit of $16.2 million; Q3 Gross Margin of 50.6%, down 150 basis points from Q3 2024 driven primarily by tariff impact Record Q3 Operating Income of
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2025 financial results after market close on Thursday, November 13, 2025. Owlet's President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 646-844-6383 (international) and reference Access Code 428622. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay w
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, August 7, 2025, at 4:30 p.m. ET. Q2 2025 Financial Highlights Q2 Revenue of $26.1 million, up 25.9% from Q2 2024 Q2 Gross Margin of 51.3%, up 180 basis points from Q2 2024 Q2 Net Loss of $37.6 million, including a $34.8 million non-cash, mark-to-market common stock w
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT) plans to announce second quarter 2025 financial results after market close on Thursday, August 7, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 579904. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay will be available
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, May 8, 2025, at 4:30 p.m. ET. Q1 2025 Financial Highlights: Q1 Revenue of $21.1 million, up 43.1% from Q1 2024 Q1 Gross Margin of 53.7%, up 930 basis points from Q1 2024 Q1 Net Income of $3.0 million, compared to $3.3 million in Q1 2024 Q1 Adjusted EBITDA of $0.0 million, improving
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT) plans to announce first quarter 2025 financial results after market close on Thursday, May 8, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 952382. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay will be available on th
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the fourth quarter and full year ended December 31, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, March 4, 2025, at 4:30 p.m. ET. Q4 2024 Financial Highlights Q4 Revenue of $20.5 million, compared to $21.0 million in Q4 2023. Excluding the revenue impact from the prior year Amazon distribution partner transition, which shifted $6 million of
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce fourth quarter and full year 2024 financial results after market close on Tuesday, March 4, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 492081. A simultaneous webcast may be accessed online at the Events section of Owlet's Inve
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, November 13, 2024, at 4:30 p.m. ET. Q3 2024 Financial Highlights: Q3 Revenue of $22.1 million, up 141% from Q3 2023 Q3 Gross Margin of 52.2%, up 1,590 basis points from Q3 2023 Q3 Net Loss of $(5.6) million, compared to $(5.6) million in Q3 2023 Q3
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2024 financial results after market close on Wednesday, November 13, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 626609. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Rela
This live feed shows all institutional transactions in real time.
SC 13G/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13G/A - Owlet, Inc. (0001816708) (Subject)
SC 13G/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13G - Owlet, Inc. (0001816708) (Subject)
SC 13D - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
Live Leadership Updates
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome
Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'